Glaucoma Insights

Study: Gene therapy could preserve vision in patients with retinal disease, serious retinal injury

Investigators uncovered evidence that CaMKII could prove to be a desirable therapeutic target for vision preservation in conditions that damage the axons and somas of retinal ganglion cells.

FDA grants Investigational Device Exemption for MINIject in glaucoma patients

According to iSTAR Medical, the STAR-V study will investigate the device in 350 patients with primary open angle glaucoma.

Studying glaucoma epidemiology at the center of the Earth

Donald L. Budenz, MD, MPH, shares the key takeaways from his Shaffer-Hetherington-Hoskins Lecture, focusing on glaucoma epidemiology, presented during the 2021 Glaucoma 360's 25th Annual Glaucoma Symposium CME.